furosemide has been researched along with ketamine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Marmo, E | 1 |
| Borchard, RE; Hanna, RM; Schmidt, SL | 1 |
| Hasegawa, J; Horisawa, A; Kainuma, M; Matsuura, M; Miyake, T; Nanba, Y; Takeshima, N | 1 |
| Helfrich, U; Liu, J; Maleck, W; Petroianu, G; Rüfer, R | 1 |
| Oguntoye, O | 1 |
1 review(s) available for furosemide and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for furosemide and ketamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Arousing agents and narcotics. Experimental study].
Topics: Anesthesia, General; Animals; Arousal; Central Nervous System Agents; Central Nervous System Stimulants; Depression, Chemical; Drug Interactions; Furosemide; Ketamine; Levodopa; Mice; Neuroleptanalgesia; Pentobarbital; Platelet Aggregation; Rabbits; Rats; Thiopental | 1978 |
Effect of diuretics on ketamine and sulfanilate elimination in cats.
Topics: Aminophylline; Animals; Benzenesulfonates; Cats; Diuretics; Female; Furosemide; Half-Life; Ketamine; Male; Mannitol; Sulfanilic Acids | 1988 |
[Multivariate analysis of the effects of diuretics, muscle relaxants and anesthesia on urine volume].
Topics: Analysis of Variance; Drug Synergism; Furosemide; Humans; Ketamine; Mannitol; Muscle Relaxants, Central; Neuroleptanalgesia; Urine | 1985 |
Phospholipase A2-induced coagulation abnormalities after bee sting.
Topics: Animals; Antithrombin III; Bee Venoms; Bees; Blood Coagulation Disorders; Blood Coagulation Tests; Cromolyn Sodium; Drug Evaluation, Preclinical; Factor V; Factor VIII; Female; Fibrinogen; Furosemide; Humans; Insect Bites and Stings; Ketamine; Lidocaine; Linear Models; Magnesium; Male; Phospholipases A; Phospholipases A2; Prothrombin | 2000 |
Effect of furosemide on dexmedetomidine anaesthesia in cats.
Topics: Anesthesia; Anesthetics; Animals; Cats; Dexmedetomidine; Female; Furosemide; Heart Rate; Ketamine; Male | 2020 |